WO2004016598A1 - Monomers capable of forming four hydrogen bridges and supramolecular polymers formed by copolymerization of these monomers with regular monomers - Google Patents

Monomers capable of forming four hydrogen bridges and supramolecular polymers formed by copolymerization of these monomers with regular monomers Download PDF

Info

Publication number
WO2004016598A1
WO2004016598A1 PCT/NL2003/000586 NL0300586W WO2004016598A1 WO 2004016598 A1 WO2004016598 A1 WO 2004016598A1 NL 0300586 W NL0300586 W NL 0300586W WO 2004016598 A1 WO2004016598 A1 WO 2004016598A1
Authority
WO
WIPO (PCT)
Prior art keywords
monomer
group
monomers
monomeric unit
copolymer
Prior art date
Application number
PCT/NL2003/000586
Other languages
French (fr)
Other versions
WO2004016598A8 (en
Inventor
Henricus Marie Janssen
Gaby Maria Leonarda Van Gemert
Aafke Tessa Ten Cate
Dimphna Johanna Maria Van Beek
Rintje Pieter Sijbesma
Egbert Willem Meijer
Anton Willem Bosman
Original Assignee
Suprapolix, B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suprapolix, B.V. filed Critical Suprapolix, B.V.
Priority to AU2003258887A priority Critical patent/AU2003258887A1/en
Priority to JP2004528958A priority patent/JP4912590B2/en
Priority to EP03788181.0A priority patent/EP1534688B1/en
Publication of WO2004016598A1 publication Critical patent/WO2004016598A1/en
Publication of WO2004016598A8 publication Critical patent/WO2004016598A8/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F246/00Copolymers in which the nature of only the monomers in minority is defined
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • C08G83/008Supramolecular polymers

Definitions

  • MONOMERS CAPABLE OF FORMING FOUR HYDROGEN BRIDGES AND SUPRAMOLECULAR POLYMERS FORMED BY COPOLYM ⁇ RIZATION OF THESE MONOMERS WITH REGULAR MONOMERS
  • the invention relates to the synthesis of polymers containing self-complementary quadruple hydrogen groups by copolymerizing monomers containing a quadruple hydrogen bonding group with one or more monomers of choice.
  • the resulting polymers 10 show unique new characteristics due to the presence of additional physical interactions between the polymer chains that are based on multiple hydrogen bonding interactions (supramolecular interactions).
  • This invention relates to polymers containing units that are capable of forming H- bridges with each other leading to physical interactions between different polymer chains.
  • the physical interactions originate from multiple hydrogen bonding interactions (supramolecular interactions) between self-complementary units containing at least 20 four hydrogen bonds (units capable of forming at least four hydrogen bonds are in this application abbreviated as 4H-units or 4H-monomers and are used in this application as interchangeable terms) in a row.
  • Sijbesma et al. US 6.320.018; Science, 278, 1601 discloses such self-complementary units which are based on 2-ureido-4-pyrimidones.
  • Examples X the 4H-unit 6-(3-butenyl)-2-butylureido-4-pyrimidone is disclosed. 25 Polymers obtained by polymerization of the carbon-carbon double bond moiety of this compound, are, however, not disclosed.
  • Telechelic polymers have been modified with 4H-units (Folmer, B.J.B. et al., Adv. Mater. 2000, Vol. 12, 874; Hirschberg et al., Macromolecules 1999, Vol. 32, 2696).
  • this has been performed after polymerization in a laborious post- 30 modification process.
  • Another drawback of these polymers containing 4H-units is that they only contain the 4H-unit coupled at the ends of the polymers. Consequently, the number of end groups is therefore limited by the amount of end groups (normally 2), and the functional units are always located on the periphery of the polymer.
  • Coates et al. discloses the copolymerization of 1-hexene and a 6-hexenyl-2-ureido-4-pyrimidone derivative with a Ziegler-Natta type nickel based catalyst and diethylaluminum chloride as cocatalyst.
  • the present invention discloses a convenient synthesis and convenient copolymerization of monomers containing a 4H-unit with other widely available monomers.
  • the present invention can be used for the preparation of a wide range of polymers with 4H hydrogen bonding units in order to provide these polymers with unique new material properties as a result of the incorporation of the 4H-units.
  • These new material properties result from the reversible nature of H-bonding interactions between the polymer chains that allow reversible changing of the material properties by external stimuli like heat or dilution. Consequently, it becomes possible to prepare materials that combine the mechanical properties of conventional macromolecules with the low melt viscosity of organic compounds.
  • the monomers comprise (a) a monomeric unit having a group that can be polymerized (or a monomeric unit having a polymerizable group), (b) a linking moiety and (c) a structural element capable of forming at least four hydrogen bridges, preferably four hydrogen bridges, wherein the monomer has the general structure:
  • the monomer containing the 4H-unit comprises a group that can be polymerized, a linker and a 4H-unit.
  • the group that can be polymerized is linked to a 4H-unit via a linker as is shown below in schematic form.
  • the monomers comprise (a) a monomeric unit having a group that can be polymerized (i.e. a monomeric unit having a polymerizable group), (b) a linking moiety and (c) a structural element capable of forming at least four hydrogen bridges, preferably four hydrogen bridges, wherein the monomer has the general structure:
  • (a) comprises monomeric units having an ethylenically unsaturated group or an ion-polymerizable group.
  • group (a) comprises monomeric units having an ethylenically unsaturated group.
  • the structural element that is capable of forming at least four hydrogen bridges has the general form (V) or (2 1 ):
  • the structural element (c) is capable of forming four hydrogen bridges which is preferred according to the invention, the structural element (c) has preferably the general form (1) or (2):
  • C-X,- and C-Y,- linkages each represent a single or double bond
  • n is 4 or more and Xi ...
  • X n represent donors or acceptors that form hydrogen bridges with the H-bridge-forming unit containing a corresponding structural element (2) linked to them, with X, representing a donor and Y,- an acceptor or vice versa.
  • Properties of the structural element having general forms (1'), (2'), (1) or (2) are disclosed in US 6.320.018 which for the US practice is incorporated herein by reference.
  • the structural elements (c) have at least four donors or acceptors, preferably four donors or acceptors, so that they can in pairs form at least four hydrogen bridges with one another.
  • the donors and acceptors are preferably O, S, and N atoms.
  • Molecules that can be used to construct the structural element (c) are nitrogen containing compounds that are reacted with isocyanates or thioisocyanates, or that are activated and reacted with primary amines, to obtain a urea moiety that is part of the quadruple hydrogen bonding site.
  • the nitrogen containing compound is preferably an isocytosine derivative (i.e. a 2-amino-4-thymidone derivative) or a triazine derivative, or a tautomer of these derivatives. More preferably, the nitrogen containing compound is an isocytosine having an alkyl or oligoethylene glycol group in the 6-position, most preferably methyl, or ethylhexyl.
  • the isocyanates or the thioisocyanates can be monofunctional isocyanates or monofunctional thioisocyanates or bifuntional diisocyanates or bifunctional thioisocyanates (for example alkyl or aryl (di)(thio)isocyanate(s)).
  • a particularly suitable structural element (c) according to the invention are the compounds shown below having general formulae (3) or (4), and tautomers thereof:
  • the structural element (c) according to formulae (3) or (4), respectively, is preferably bonded to the linking moiety (b) at Ri, R 2 or R 3 (so that R ls R 2 or R 3 represent a direct bond) with the other R groups representing a random side chain or are hydrogen atoms. More preferably, the structural element (c) is bonded to the linking moiety (b) at Ri (so that Ri represents a direct bond) whereas R 2 and R 3 are a random side chain or are hydrogen atoms. Most preferably, R 2 is a random side chain and R 3 a hydrogen atom, wherein the random side chain is an alkyl or oligoethylene glycol group in the 6-position, most preferably methyl, or ethylhexyl.
  • the linking moiety (b) may be all kinds of shorter or longer chains, for example saturated or unsaturated, branched, cyclic or linear alkyl chains, siloxane chains, ester chains, ether chains and any chain of atoms used in traditional polymer chemistry, whether or not substituted with functional groups such as esters, ethers, ureas or urethanes.
  • the linking moiety (b) is a C ⁇ -C 20 straight chain or branched alkylene, arylene, alkarylene or arylalkylene group, more preferably a C 2 -C ⁇ 0 straight chain or branched alkylene, arylene, alkarylene or arylalkylene group, wherein the alkylene, arylene, alkarylene or arylalkylene group may be substituted with other groups or may contain cyclic groups as substituent or in the main chain.
  • alkylene, arylene, alkarylene or arylalkylene groups may be interrupted by heteroatoms, in particular heteroatoms selected from the group of oxygen, nitrogen, and sulphur.
  • the linking moiety (b) that links the monomeric unit having a polymerizable group (a) to structural element (c) is derived from a compound that must have at least two functional groups, e.g.
  • linking moieties (b) are derived are preferably those having isocyanate or thioisocyanate end groups, more preferably isocyanate end groups. Most preferably, these compounds are diisocyanates or dithioisocyanates, in particular diisocyanates.
  • diisocyanates examples include: l,4-diisocyanato-4-methyl-pentane, 1 ,6-diisocyanato-2,2,4-trimethylhexane, l,6-diisocyanato-2,4,4-trimethylhexane, 1 ,5-diisocyanato-5-methylhexane, 3(4)-isocyanatomethyl-l-methylcyclohexyl isocyanate, 1 ,6-diisocyanato-6-methyl-heptane, 1 ,5-diisocyanato-2,2,5-trimethylhexane, l,7-diisocyanato-3,7-dimethyloctane, 1 -isocyanato-1 -methyl-4-(4-isocyanatobut-2-yl)-cyclohexane, l-isocyanato-l,2,2-trimethyl-3-(2-
  • EVICT isocyanatomethyl-l-methylcyclohexyl isocyanate
  • TDI toluene diisocyanate
  • MDI methylene diphenyl diisocyanate
  • MDI methylene dicyclohexane 4,4-diisocyanate
  • IPDI isophorone diisocyanate
  • HDI hexane diisocyanate
  • suitable thioisocyanates are the dithioisocyanate derivatives of the compounds exemplified above for suitable dithiocyanates.
  • the diisocyanate is IPDI, HDI, MDI, TDI or methylene dicyclohexane 4,4-diisocyanate and their thioisocyanate counterparts. According to the invention, however, the diisocyanates are more preferably used than dithioisocyanates.
  • the monomeric unit having a polymerizable group (a) can be any monomeric unit having a polymerizable group.
  • the monomeric unit having a polymerizable group (a) comprises preferably monomeric units having an ethylenically unsaturated group or an ion-polymerizable group and most preferably the monomeric unit having a polymerizable group comprises a monomeric unit having an ethylenically unsaturated group, i.e. a group derived from monomers having a carbon carbon double bond.
  • the monomeric unit having a polymerizable group has at least one functional group such as hydroxy, carboxylic acid, carboxylic ester, ester halide, isocyanate, thioisocyanate, primary amine, secondary amine or halogen groups.
  • the monomeric unit having a polymerizable group is derived from acrylates, methacrylates, acrylamides, methacrylamides, styrenes, vinyl-pyridines, other vinyl monomers, lactones, other cyclic esters, lactams, cyclic ethers and cyclic siloxanes.
  • the monomeric unit having a polymerizable group is derived from acrylates, methacrylates and vinyl esters, most preferably vinyl acetates.
  • Examples of compounds from the monomeric units having a polymerizable group that are in particular useful in carrying out the invention are: 2-hydroxyethyl acrylate, 2-hydroxy-pro ⁇ yl acrylate, 2,3-dihydroxypropyl acrylate, poly(ethylene glycol) acrylate, acrylamide, N-hydroxymethyl acrylamide, 2- hydroxyethyl methacrylate, 2-hydroxy-propyl methacrylate, 2,3-dihydroxypropyl methacrylate, polyethylene glycol) methacrylate, N,N- dimethylaminoethylmethacrylate, N-hydroxymethyl methacrylamide, vinylacetate, 4- vinyl phenol, 4-vinyl aniline, 4-hydroxymethyl-styrene, 4-aminomethyl-styrene, 4(2- hydroxyethyl)- ⁇ -caprolactone, 4(4-hydroxyphenyl)- ⁇ -caprolactone, and 2,3-epoxy-l- propanol.
  • the monomers are preferably prepared by the following methods.
  • the monomeric unit having a polymerizable group is reacted in a first step with the compound that must have at least two functional groups.
  • the product obtained in the first step is reacted with the nitrogen containing compound.
  • Suitable and preferred structures of the monomeric unit having a polymerizable group, the compound that must have at least two functional groups and the nitrogen containing compound are described above.
  • the nitrogen containing compound is reacted in a first step with the compound that must have at least two functional groups.
  • the product obtained in the first step is reacted with the monomeric unit having a polymerizable group.
  • the nitrogen containing compound is reacted directly with the monomeric unit having a polymerizable group wherein the monomeric unit is able to form a urea linkage between both reactants.
  • the monomeric unit having a polymerizable group is most preferably selected from the group of monomeric units having an ethylenically unsaturated group, in particular monomers having a carbon carbon double bond, wherein the monomeric unit having a polymerizable group has preferably at least one functional group, wherein the functional group is selected from the group of hydroxy, carboxylic acid, carboxylic ester, ester halide, isocyanate, thioisocyanate, primary amine, secondary amine or halogen groups.
  • the monomeric unit having a polymerizable group is selected from the group of acrylates, methacrylates, acrylamides, methacrylamides, styrenes, vinyl-pyridines, other vinyl monomers, lactones, other cyclic esters, lactams, cyclic ethers and cyclic siloxanes having a functional group selected from hydroxy, carboxylic acid, carboxylic ester, isocyanate, thioisocyanate, primary amine, secondary amine or halogen groups.
  • the monomeric unit having a polymerizable group is selected from the group of acrylates, methacrylates and vinyl esters, in particular vinyl acetates, said acrylates, methacrylates and vinyl esters having preferably a functional group selected from hydroxy, carboxylic acid, carboxylic ester, ester halide, isocyanate, thioisocyanate, primary amine, secondary amine or halogen groups.
  • R 2 and R 3 are as defined above, R 4 is hydrogen or methyl, A is a chain, preferably an oligomethylene chain or an oligoethylene glycol chain (as will be appreciated by the person skilled in the art, A may be absent so that the monomeric unit having a polymerizable group has a carboxylic group as functional group) and B is the chain of the linking moiety (b) described above.
  • Re and R 7 represent each independently a C ⁇ -C 6 alkyl group, wherein R 7 is preferably methyl.
  • the polymers presented in this invention are obtained by co-polymerizing the monomer containing the 4H-unit with one or more, optionally different comonomers that can be from the same family or from a different family of monomers.
  • These comonomers are preferably selected from the group of: acrylic acid; C ⁇ -C 30 branched or linear alkyl esters of acrylic acid; methacrylic acid; C ⁇ -C 3 o branched or linear alkyl esters of methacrylic acid; acrylamides or methacrylamides wherein the amide group may be substituted with one or two C ⁇ -C 30 branched or linear alkyl groups; vinyl esters, preferably vinyl acetates; other compounds having a vinyl group wherein said compounds are preferably selected from pyrrolidones, imidazoles, pyridines, caprolactams, piperidones, benzene and derivatives thereof; C 4 -C 20 alkadienes; lactones; lactams; and saturated or uns
  • Suitable comonomers are acrylic acid, methyl acrylate, butyl acrylate, 2-ethylhexyl acrylate, 2-hydroxyethyl acrylate, N,N- dimethylacrylamide, N-isopropylacrylamide, methacrylic acid, methyl methacrylate, ethyl methacrylate, butyl methacrylate, isobutyl methacrylate, 2-ethylhexyl methacrylate, lauryl methacrylate, 2-hydroxy-ethyl methacrylate, vinylacetate, N- vinylpyrrolidinone, 2-vinylpyridine-l -oxide, N-vinyl imidazole, N- vinyl pyridine, N- vinylcaprolactam, N-vinyl-2-piperidone, acrylonitrile, styrene, butadiene, isoprene, caprolacton, butyrolacton, caprolactam, ethyleenoxide, prop
  • the copolymerizations may be of any type (for example, bulk, dispersion, solution, emulsion, suspension or inverse phase emulsion) and of any mechanism (for example, radical polymerization, condensation polymerization, transition metal catalyzed polymerization, enzymatic polymerization, or ring opening polymerization).
  • the copolymer backbone acquired may be of any type (linear, branched, star, hyperbranched, dendritic, comb-like or the like).
  • the product copolymer may be of any structure. For example random, regular, tapered or block copolymer structures are allowed.
  • the molecular weights of the polymers are preferably not too high.
  • a preferred number average molecular weight range is 500 - 20000.
  • copolymers according to the invention are in particular suitable for applications related to personal care (hair preparations, skin cosmetics and laundry aids), surface coatings (leather, textile, optical fibers, paper and paint formulations), imaging technologies (printing, stereolithography, photography and lithography), biomedical applications (materials for controlled release of drugs and materials for tissue-engineering, tablet formulation), adhesive and sealing compositions, and thickening agent and binders.
  • 1,6-Hexyldiisocyanate 650 g
  • methyl isocytosine or 2-amino-4-hydroxy-6- methyl-pyrimidine, 65.1 g
  • the mixture was stirred overnight at 100 °C under an argon atmosphere. After cooling to room temperature, a liter of pentane was added to the suspension, while stirring was continued. The product was filtered, washed with pentane and dried in vacuum. A white powder was obtained.
  • 1HNMR 400 MHz, CDC1 3
  • FT-IR v 2935, 2281, 1698, 1668, 1582, 1524, 1256.
  • Methyl isocytosine (5.2 g) was added to isophoronediisocyanate (IPDI, 50 mL) and subsequently stirred at 90 °C under an argon atmosphere for 3 days. The resulting clear solution was precipitated in heptane. The white gom was collected, heated in 150 mL heptane, cooled on ice, and filtered. The same procedure was repeated once more with the white residue, resulting in a white powder.
  • 1H N R 400 MHz, CDC1 3 ): ⁇ 13.1 (1H), 12.0 (1H), 10.1 (1H), 5.9 (1H), 4.1-3.1 (3H), 2.1 (3H), 2.0-0.9 (15H).
  • FT-IR (neat): v (cm "1 ) 2954, 2255, 1696, 1662, 1582, 1524, 1247.
  • Methyl isocytosine (2.0 g) was added to 4,4'-methylenebis(phenylisocyanate) (MDI, 8.1 g) dissolved in 35 mL THF and subsequently stirred at an oil bath temperature of 75 °C under an argon atmosphere. After 4 hours, 40 mL chloroform was added and the white precipitate was separated by filtration and washed with chloroform.
  • 1H NMR 400 MHz, DMSO-d6): ⁇ 10.0 (1H), 8.6 (1H), 7.4 (5H), 7.2 (4H), 5.8 (1H), 3.8 (2H), 2.1 (3H).
  • FT-IR (neat): v (cm "1 ) 3329, 2954, 2257, 1699, 1658, 1578, 1508, 1244.
  • Example 4 synthesis of isocyanate IV
  • a suspension of methyl isocytosine (2 g) and trimethyl-l,6-hexyldiisocyanate (a mixture of 2,2,4-trimethyl and 2,4,4-trimethyl isomers; 24 g) was stirred and heated for 21 hours at an oil bath temperature of 100 °C. The mixture was kept under an argon atmosphere. The reaction mixture was cooled down to room temperature and pentane was added to induce precipitation. The suspension was filtrated over a glass filter and the gummy residue was stirred and heated again in pentane. Cooling, filtration and drying gave a white powder.
  • Potassium ethyl malonate (150 g) and acetonitrile (1.4 L) were stirred in a flask and brought to a temperature of 10-15 °C.
  • Triethylamine (132 mL) was added drop wise, while keeping the mixture under an argon atmosphere.
  • Dried MgCl 2 (101.6 g) was added and the suspension was stirred for 2 hours at room temperature. Thereafter, the suspension was cooled to 0 °C and 2-ethylhexanoyl chloride (74 mL) was added drop wise, and the mixture was allowed to warm up to room temperature and was stirred overnight.
  • the acetonitrile was removed by evaporation, 400 mL toluene was added and evaporated, 700 mL of toluene was added and the mixture was cooled to 10 °C.
  • An aqueous HC1 solution was added slowly, and the organic layer was separated, washed with an HC1 solution and then with a bicarbonate solution.
  • the organic layer was dried with Na 2 SO 4 and concentrated to give the ⁇ -ketoester as a liquid.
  • the ⁇ -ketoester (50 g) and guanidine carbonate (49.8 g) were boiled in ethanol (300 mL) for two days using a Soxhlett set-up with molsieves in the thimble.
  • Example 6 monomer 1, a 4H hydrogen bonding unit containing methacrylate monomer
  • Isocyanate II (28 g) was dissolved in chloroform (0.5 L), and thereafter hydroxy ethyl methacrylate (HEMA, 9.6 mL) and 8 drops of dibutyl tin dilaurate (DBTDL) were added. The mixture was stirred at an oil bath temperature of 90 °C for 4 hours, and was then cooled and filtered. The filtrate was concentrated and dropped into an excess of diethylether. The precipitate was collected by filtration, and was washed with diethylether. Drying in vacuo gave a solid product.
  • HEMA hydroxy ethyl methacrylate
  • DBTDL dibutyl tin dilaurate
  • Example 7 monomer 2, a 4H hydrogen bonding unit containing acrylate monomer
  • Isocyanate I 46 g was suspended in chloroform (1 L), and thereafter hydroxy ethyl acrylate (HEA, 36 mL) and 10 drops of dibutyl tin dilaurate (DBTDL) were added. The mixture was stirred at an oil bath temperature of 90 °C for 4 hours, and was then cooled and filtered. The filtrate was concentrated and an excess of diethylether was added. The white precipitate was collected by filtration, and was washed with diethylether. Drying in vacuo gave a white solid product.
  • HOA hydroxy ethyl acrylate
  • DBTDL dibutyl tin dilaurate
  • Example 8 monomer 3, a 4H hydrogen bonding unit containing methacrylate monomer
  • 2-Isocyanatoethyl methacrylate (7.0 mL) was added to a solution of 6-(l-ethylpentyl)- isocytosine (13.4 g) in dry pyridine (150 mL). The reaction mixture was stirred under an argon atmosphere at 80 °C for 4 hrs. The product was worked-up by evaporation of the solvent, and subsequent filtration over silica using chloroform/methanol (4%).
  • Example 9 monomer 4, a 4H hydrogen bonding unit containing methacrylate monomer
  • Example 10 monomer 5, a 4H hydrogen bonding unit containing acrylamide monomer
  • Isocyanate I (1 g) was dissolved in 5 mL of acrylic acid and heated to 60 °C. The mixture was stirred under an argon atmosphere. Copper(II)acetate (8 mg) was added and heating at 60 °C was maintained for 2 hours. The product was obtained by precipitation of the reaction mixture into diethylether. Then the solid was filtered, dissolved in chloroform and washed with a bicarbonate solution. Drying with Na SO 4 and column chromatography using chloroform with 10% methanol gave a white powder.
  • Example 11 monomer 6, a 4H hydrogen bonding unit containing vinyl-ester monomer
  • 6-(l-Ethylpentyl)-isocytosine (3.5 g) was dissolved in 50 mL THF followed by the addition of 2.5 mL ethyl 3-isocyanato ethylacetate. Stirring the reaction mixture under reflux for 16h resulted in the formation of a white powder that was filtered and washed 5 with chloroform (4.8 gram). This compound was subsequently dissolved in a mixture of ethanol (50 mL) and 1 N aqueous sodium hydroxide (40 mL) and stirred for 2 h at room temperature.
  • Example 12 monomer 7, a 4H hydrogen bonding unit containing styrene monomer
  • Isocyanate I (5.6 g) was added to 4-aminostyrene (obtained from Aldrich 1.9 g) dissolved in 50 mL of chloroform and subsequently heated to 70 °C. The mixture was stirred under an argon atmosphere for 12h. The product was obtained by separation of the yellowish precipitate from the reaction mixture by filtration, followed by washing with chloroform.
  • 1H NMR 400 MHz, CDCl 3 /DMSO-d6): ⁇ 7.8 (IH), 7.2 (4H), 6.6 (IH), 5.8 (IH), 5.5 (IH), 5.1 (IH), 3.4-3.2 (4H), 2.1 (3H), 1.7-1.2 (8H).
  • FT-IR (neat): v 3278, 2935, 1699, 1665, 1652, 1582, 1525.
  • Example 13 monomer 8, a 4H hydrogen bonding unit containing ⁇ -lacton monomer
  • Example 14 monomer 9, a 4H hydrogen bonding unit containing acrylate monomer
  • Isocyanate IN (11 g) was dissolved in chloroform (150 mL), and thereafter hydroxy ethyl acrylate (HEA, 4.1 mL) and 4 drops of dibutyl tin dilaurate (DBTDL) were added. The mixture was stirred at an oil bath temperature of 60 °C for 9 hours, and was then cooled and precipitated in pentane, followed by a washing step with diethylether.
  • HOA hydroxy ethyl acrylate
  • DBTDL dibutyl tin dilaurate
  • the white powder was collected by filtration, and was washed with diethylether.
  • Example 15 monomer 10, a 4H hydrogen bonding unit containing methacrylate monomer
  • the isocyanate (79 g) was suspended in chloroform (1.5 L), and thereafter hydroxy ethyl methacrylate (HEMA, 64 mL) and 15 drops of dibutyl tin dilaurate (DBTDL) were added. The mixture was stirred at an oil bath temperature of 90 °C for 4 hours, and was then cooled and filtered. The filtrate was concentrated and dropped into an excess of diethylether. The white precipitate was collected by filtration, and was washed with diethylether. Drying in vacuo gave a white solid product (90 g). !
  • a 25 mL round bottom flask containing CuBr (ca. 1 equiv. to initiator; typically 0.06 to 0.31 g), 2,2'-bipyridine (ca. 2 equiv. to initiator) and the appropriate amount of 4H hydrogen bonding unit containing monomer was degassed (de-oxygenated) by vacuum followed by argon backfill, and repeating this cycle twice.
  • the reaction mixture was stirred until all components had dissolved (sometimes after short warming) to produce a homogeneous dark brown solution.
  • the reaction flask was placed in a water bath that was maintained at room temperature, and finally, the ATRP- initiator (benzyl-2-bromo-2-methyl-propionate) was added using a syringe.
  • the molar ratio of ATRP initiator to HEMA was about 1:40 (for polymers A, C, D and E) and about 1:20 for polymer B. Polymerization occurred immediately, leading to an increase in viscosity of the reaction mixture.
  • the polymer was isolated by precipitation into an EDTA (25 gL) solution in water (polymers B-E), or in chloroform (polymer A). The polymer was washed and dried.
  • a flask containing NiBr 2 (PPh 3 ) 2 (ca. 0.35 g) and, optionally, the 4H hydrogen bonding unit containing monomer 3 was degassed (de-oxygenated) by vacuum followed by argon backfill, and repeating this cycle twice.
  • MMA and toluene in equal volumes; both 5 mL were degassed (de-oxygenated) by bubbling through argon for at least 45 minutes, and were then added to the flask by use of a syringe.
  • the ATRP- initiator (benzyl-2-bromo-2-methyl-propionate, ca.
  • Emulsion polymerization (EP) procedure (polymers N and O)
  • Butyl acrylate (5 mL), water (11 mL), optionally monomer 9 (0.67 g), sodium dodecyl sulphate (0.1 g), charge transfer agent dodecyl mercaptane (0.3 mL), initiator sodium persulphate (25 mg for polymer N and 50 mg for polymer O) and sodium bicarbonate (30 mg for polymer N and 25 mg for polymer O) were mixed at 20 °C and purged with argon for 45 minutes. Subsequently, the reaction temperature was raised to 50 °C and the mixture was extensively stirred for 4 hours. The polymer product was isolated after coagulation of the emulsion by addition of methanol.
  • Molecular weights (M n ) of polymers A-E, and M were determined with 1H NMR by considering the integral of the benzylic end group versus the integral of the repeating unit.
  • the molecular weights (Mn) and dispersities (D) of polymers B, C and I were determined with SEC (0.01 M LiBr in DMF) against polystyrene standards (a comparison with the NMR data for polymers B and C shows that the Mn and D values from the SEC-measurements are overrated).
  • the molecular weights (Mn or Mtop) and dispersities (D) of polymers F, G, N and O were determined with SEC (THF) against polystyrene standards.
  • 1H NMR in deuterated chloroform or DMSO-d 6 has been used to calculate the average number of 4H hydrogen bonding units per polymer chain by considering the integral of the benzylic signals of the polymer end group and the integral of the alkylidene signal of the 4H hydrogen bonding unit in case of polymers A-G and M.
  • Polymers H-L and N contain incorporated 4H hydrogen bonding units, as evidenced by 1H NMR data.
  • polymer F and G have a comparable molecular weight, see table 1.
  • incorporación of 4H hydrogen bonding units in polymers according to this invention also gives enhancement in material properties, as most clearly reflected in the difference in properties of polymers N and O. While poly(butylacrylate) O is a sticky viscous liquid, poly(butylacrylate) N with incorporated 4H hydrogen bonding units is an elastic material even despite the fact that polymer N has a lower molecular weight than polymer O.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Polyesters Or Polycarbonates (AREA)

Abstract

The invention relates to the synthesis of polymers containing self-complementary quadruple hydrogen groups by copolymerizing monomers containing a quadruple hydrogen bonding group with one or more monomers of choice. The resulting polymers show unique new characteristics due to the presence of additional physical interactions between the polymer chains that are based on multiple hydrogen bonding interactions (supramolecular interactions).

Description

MONOMERS CAPABLE OF FORMING FOUR HYDROGEN BRIDGES AND SUPRAMOLECULAR POLYMERS FORMED BY COPOLYMΞRIZATION OF THESE MONOMERS WITH REGULAR MONOMERS
5 FIELD OF THE INVENTION
The invention relates to the synthesis of polymers containing self-complementary quadruple hydrogen groups by copolymerizing monomers containing a quadruple hydrogen bonding group with one or more monomers of choice. The resulting polymers 10 show unique new characteristics due to the presence of additional physical interactions between the polymer chains that are based on multiple hydrogen bonding interactions (supramolecular interactions).
BACKGROUND OF THE INVENTION
15
This invention relates to polymers containing units that are capable of forming H- bridges with each other leading to physical interactions between different polymer chains. The physical interactions originate from multiple hydrogen bonding interactions (supramolecular interactions) between self-complementary units containing at least 20 four hydrogen bonds (units capable of forming at least four hydrogen bonds are in this application abbreviated as 4H-units or 4H-monomers and are used in this application as interchangeable terms) in a row. Sijbesma et al. (US 6.320.018; Science, 278, 1601) discloses such self-complementary units which are based on 2-ureido-4-pyrimidones. In Examples X the 4H-unit 6-(3-butenyl)-2-butylureido-4-pyrimidone is disclosed. 25 Polymers obtained by polymerization of the carbon-carbon double bond moiety of this compound, are, however, not disclosed.
Telechelic polymers have been modified with 4H-units (Folmer, B.J.B. et al., Adv. Mater. 2000, Vol. 12, 874; Hirschberg et al., Macromolecules 1999, Vol. 32, 2696). However, this has been performed after polymerization in a laborious post- 30 modification process. Another drawback of these polymers containing 4H-units is that they only contain the 4H-unit coupled at the ends of the polymers. Consequently, the number of end groups is therefore limited by the amount of end groups (normally 2), and the functional units are always located on the periphery of the polymer.
Polymers containing hydrogen bonding groups in the main chain synthesized via copolymerization of hydrogen bonding monomers have been obtained with hydrogen bonding units containing three H-bonds in a row (Lange F.M. et al., Macromolecules 1995, Vol 28, 782). However, only an alternating copolymer of styrene and maleimide can be used in this approach, and moreover, the H-bonding interactions between the polymers are much weaker than the H-bonding based on the 4H-units, obviously resulting in poorer material properties. Polymers with quadruple H-bonding units in the main chain have been obtained by copolymerizing 4H-monomers in the main chain of a polyolefin (Coates, G.W. et al., Angew. Chem. Int. Ed., 2001, Vol. 40, 2153). However, complex chemistry has to be used to prepare and to polymerize the monomer and, due to the intrinsic sensitivity of the catalyst needed to obtain the polymer, severe limitations hinder the general use of this system and limits it to tailor-made polyolefin systems. For example, Coates et al. discloses the copolymerization of 1-hexene and a 6-hexenyl-2-ureido-4-pyrimidone derivative with a Ziegler-Natta type nickel based catalyst and diethylaluminum chloride as cocatalyst.
The present invention discloses a convenient synthesis and convenient copolymerization of monomers containing a 4H-unit with other widely available monomers. The present invention can be used for the preparation of a wide range of polymers with 4H hydrogen bonding units in order to provide these polymers with unique new material properties as a result of the incorporation of the 4H-units. These new material properties result from the reversible nature of H-bonding interactions between the polymer chains that allow reversible changing of the material properties by external stimuli like heat or dilution. Consequently, it becomes possible to prepare materials that combine the mechanical properties of conventional macromolecules with the low melt viscosity of organic compounds. SUMMARY OF THE INVENTION
According to the invention, the monomers comprise (a) a monomeric unit having a group that can be polymerized (or a monomeric unit having a polymerizable group), (b) a linking moiety and (c) a structural element capable of forming at least four hydrogen bridges, preferably four hydrogen bridges, wherein the monomer has the general structure:
(a) - (b) - (c)
DETAILED DESCRIPTION OF THE INVENTION
Description of the monomer containing the 4H-unit
The monomer containing the 4H-unit comprises a group that can be polymerized, a linker and a 4H-unit. In particular, the group that can be polymerized is linked to a 4H-unit via a linker as is shown below in schematic form.
Figure imgf000004_0001
According to the invention, the monomers comprise (a) a monomeric unit having a group that can be polymerized (i.e. a monomeric unit having a polymerizable group), (b) a linking moiety and (c) a structural element capable of forming at least four hydrogen bridges, preferably four hydrogen bridges, wherein the monomer has the general structure:
(a) - (b) - (c)
Preferably, (a) comprises monomeric units having an ethylenically unsaturated group or an ion-polymerizable group. Most preferably, group (a) comprises monomeric units having an ethylenically unsaturated group. In general, the structural element that is capable of forming at least four hydrogen bridges has the general form (V) or (21):
Figure imgf000005_0001
d') (2')
If the structural element (c) is capable of forming four hydrogen bridges which is preferred according to the invention, the structural element (c) has preferably the general form (1) or (2):
Figure imgf000005_0002
In all general forms shown above the C-X,- and C-Y,- linkages each represent a single or double bond, n is 4 or more and Xi ... Xn represent donors or acceptors that form hydrogen bridges with the H-bridge-forming unit containing a corresponding structural element (2) linked to them, with X, representing a donor and Y,- an acceptor or vice versa. Properties of the structural element having general forms (1'), (2'), (1) or (2) are disclosed in US 6.320.018 which for the US practice is incorporated herein by reference. The structural elements (c) have at least four donors or acceptors, preferably four donors or acceptors, so that they can in pairs form at least four hydrogen bridges with one another. Preferably the structural elements (c) have at least two successive donors, followed by at least two acceptors, preferably two successive donors followed by two successive acceptors, preferably structural elements according to general form (l1) or more preferably (1) with n=4, in which Xi and X2 both represent a donor and an acceptor, respectively, and X3 and X4 both an acceptor and a donor, respectively. According to the invention, the donors and acceptors are preferably O, S, and N atoms. Molecules that can be used to construct the structural element (c) are nitrogen containing compounds that are reacted with isocyanates or thioisocyanates, or that are activated and reacted with primary amines, to obtain a urea moiety that is part of the quadruple hydrogen bonding site. The nitrogen containing compound is preferably an isocytosine derivative (i.e. a 2-amino-4-thymidone derivative) or a triazine derivative, or a tautomer of these derivatives. More preferably, the nitrogen containing compound is an isocytosine having an alkyl or oligoethylene glycol group in the 6-position, most preferably methyl, or ethylhexyl. The isocyanates or the thioisocyanates can be monofunctional isocyanates or monofunctional thioisocyanates or bifuntional diisocyanates or bifunctional thioisocyanates (for example alkyl or aryl (di)(thio)isocyanate(s)).
A particularly suitable structural element (c) according to the invention are the compounds shown below having general formulae (3) or (4), and tautomers thereof:
Figure imgf000006_0001
The structural element (c) according to formulae (3) or (4), respectively, is preferably bonded to the linking moiety (b) at Ri, R2 or R3 (so that Rls R2 or R3 represent a direct bond) with the other R groups representing a random side chain or are hydrogen atoms. More preferably, the structural element (c) is bonded to the linking moiety (b) at Ri (so that Ri represents a direct bond) whereas R2 and R3 are a random side chain or are hydrogen atoms. Most preferably, R2 is a random side chain and R3 a hydrogen atom, wherein the random side chain is an alkyl or oligoethylene glycol group in the 6-position, most preferably methyl, or ethylhexyl. The linking moiety (b) may be all kinds of shorter or longer chains, for example saturated or unsaturated, branched, cyclic or linear alkyl chains, siloxane chains, ester chains, ether chains and any chain of atoms used in traditional polymer chemistry, whether or not substituted with functional groups such as esters, ethers, ureas or urethanes. Preferably, the linking moiety (b) is a Cι-C20 straight chain or branched alkylene, arylene, alkarylene or arylalkylene group, more preferably a C2-Cι0 straight chain or branched alkylene, arylene, alkarylene or arylalkylene group, wherein the alkylene, arylene, alkarylene or arylalkylene group may be substituted with other groups or may contain cyclic groups as substituent or in the main chain. Examples of such groups are methylene, ethylene, propylene, tetramethylene, pentamethylene, hexamethylene heptamethylene, octamethylene, nonamethylene, 1,6- bis(ethylene)cyclohexane, 1,6-bismethylene benzene, etc. The alkylene, arylene, alkarylene or arylalkylene groups may be interrupted by heteroatoms, in particular heteroatoms selected from the group of oxygen, nitrogen, and sulphur. The linking moiety (b) that links the monomeric unit having a polymerizable group (a) to structural element (c) is derived from a compound that must have at least two functional groups, e.g. hydroxy, carboxylate, carboxylic ester, ester halide, isocyanate, thioisocyanate, primary amine, secondary arnine, or halogen functions. These functional groups are preferably present as end groups. According to the invention, such preferred compounds from which the linking moieties (b) are derived are preferably those having isocyanate or thioisocyanate end groups, more preferably isocyanate end groups. Most preferably, these compounds are diisocyanates or dithioisocyanates, in particular diisocyanates. Examples of suitable diisocyanates that can be used in this invention are: l,4-diisocyanato-4-methyl-pentane, 1 ,6-diisocyanato-2,2,4-trimethylhexane, l,6-diisocyanato-2,4,4-trimethylhexane, 1 ,5-diisocyanato-5-methylhexane, 3(4)-isocyanatomethyl-l-methylcyclohexyl isocyanate, 1 ,6-diisocyanato-6-methyl-heptane, 1 ,5-diisocyanato-2,2,5-trimethylhexane, l,7-diisocyanato-3,7-dimethyloctane, 1 -isocyanato-1 -methyl-4-(4-isocyanatobut-2-yl)-cyclohexane, l-isocyanato-l,2,2-trimethyl-3-(2-isocyanato-ethyl)-cyclopentane, 1 -isocyanato- 1 ,4-dimethyl-4-isocyanatomethyl-cyclohexane, 1 -isocyanato- 1 ,3 -dimethyl-3 -isocyanatomethyl-cyclohexane, 1 -isocyanatol-n-butyl-3-(4-isocyanatobut- 1 -yl)-cyclopentane. 1 -isocyanato- 1 ,2-dimethyl-3 -ethyl-3 -isocyanatomethyl-cyclopentane, 3(4)-isocyanatomethyl-l-methylcyclohexyl isocyanate (EVICT), toluene diisocyanate (TDI), methylene diphenyl diisocyanate (MDI), methylene dicyclohexane 4,4-diisocyanate, isophorone diisocyanate (IPDI), hexane diisocyanate (HDI). Examples of suitable thioisocyanates are the dithioisocyanate derivatives of the compounds exemplified above for suitable dithiocyanates.
Preferably, the diisocyanate is IPDI, HDI, MDI, TDI or methylene dicyclohexane 4,4-diisocyanate and their thioisocyanate counterparts. According to the invention, however, the diisocyanates are more preferably used than dithioisocyanates. The monomeric unit having a polymerizable group (a) can be any monomeric unit having a polymerizable group. The monomeric unit having a polymerizable group (a) comprises preferably monomeric units having an ethylenically unsaturated group or an ion-polymerizable group and most preferably the monomeric unit having a polymerizable group comprises a monomeric unit having an ethylenically unsaturated group, i.e. a group derived from monomers having a carbon carbon double bond. According to a preferred embodiment of the invention, the monomeric unit having a polymerizable group has at least one functional group such as hydroxy, carboxylic acid, carboxylic ester, ester halide, isocyanate, thioisocyanate, primary amine, secondary amine or halogen groups. According to a more preferred embodiment of the invention, the monomeric unit having a polymerizable group is derived from acrylates, methacrylates, acrylamides, methacrylamides, styrenes, vinyl-pyridines, other vinyl monomers, lactones, other cyclic esters, lactams, cyclic ethers and cyclic siloxanes. According to the most preferred embodiment of the invention, the monomeric unit having a polymerizable group is derived from acrylates, methacrylates and vinyl esters, most preferably vinyl acetates. Examples of compounds from the monomeric units having a polymerizable group that are in particular useful in carrying out the invention are: 2-hydroxyethyl acrylate, 2-hydroxy-proρyl acrylate, 2,3-dihydroxypropyl acrylate, poly(ethylene glycol) acrylate, acrylamide, N-hydroxymethyl acrylamide, 2- hydroxyethyl methacrylate, 2-hydroxy-propyl methacrylate, 2,3-dihydroxypropyl methacrylate, polyethylene glycol) methacrylate, N,N- dimethylaminoethylmethacrylate, N-hydroxymethyl methacrylamide, vinylacetate, 4- vinyl phenol, 4-vinyl aniline, 4-hydroxymethyl-styrene, 4-aminomethyl-styrene, 4(2- hydroxyethyl)-ε-caprolactone, 4(4-hydroxyphenyl)-ε-caprolactone, and 2,3-epoxy-l- propanol.
According to the invention, the monomers are preferably prepared by the following methods.
According to a first method, the monomeric unit having a polymerizable group is reacted in a first step with the compound that must have at least two functional groups. In a subsequent step, the product obtained in the first step is reacted with the nitrogen containing compound. Suitable and preferred structures of the monomeric unit having a polymerizable group, the compound that must have at least two functional groups and the nitrogen containing compound are described above. According to a second method, the nitrogen containing compound is reacted in a first step with the compound that must have at least two functional groups. In a subsequent step, the product obtained in the first step is reacted with the monomeric unit having a polymerizable group.
According to a third method, the nitrogen containing compound is reacted directly with the monomeric unit having a polymerizable group wherein the monomeric unit is able to form a urea linkage between both reactants.
According to these methods, the monomeric unit having a polymerizable group is most preferably selected from the group of monomeric units having an ethylenically unsaturated group, in particular monomers having a carbon carbon double bond, wherein the monomeric unit having a polymerizable group has preferably at least one functional group, wherein the functional group is selected from the group of hydroxy, carboxylic acid, carboxylic ester, ester halide, isocyanate, thioisocyanate, primary amine, secondary amine or halogen groups. More preferably, the monomeric unit having a polymerizable group is selected from the group of acrylates, methacrylates, acrylamides, methacrylamides, styrenes, vinyl-pyridines, other vinyl monomers, lactones, other cyclic esters, lactams, cyclic ethers and cyclic siloxanes having a functional group selected from hydroxy, carboxylic acid, carboxylic ester, isocyanate, thioisocyanate, primary amine, secondary amine or halogen groups. Even more preferably, the monomeric unit having a polymerizable group is selected from the group of acrylates, methacrylates and vinyl esters, in particular vinyl acetates, said acrylates, methacrylates and vinyl esters having preferably a functional group selected from hydroxy, carboxylic acid, carboxylic ester, ester halide, isocyanate, thioisocyanate, primary amine, secondary amine or halogen groups.
Preferred embodiments of the methods for the preparation of the monomers are shown below in Schemes 1 - 3.
Scheme 1
Figure imgf000010_0001
wherein R2 and R3 are as defined above, R4 is hydrogen or methyl, A is a chain, preferably an oligomethylene chain or an oligoethylene glycol chain (as will be appreciated by the person skilled in the art, A may be absent so that the monomeric unit having a polymerizable group has a carboxylic group as functional group) and B is the chain of the linking moiety (b) described above.
Scheme 2
Figure imgf000010_0002
Scheme 3
Figure imgf000011_0001
In Scheme 3 Re and R7 represent each independently a Cι-C6 alkyl group, wherein R7 is preferably methyl.
Description of the co-polymerization and of the polymer
The polymers presented in this invention are obtained by co-polymerizing the monomer containing the 4H-unit with one or more, optionally different comonomers that can be from the same family or from a different family of monomers. These comonomers are preferably selected from the group of: acrylic acid; Cι-C30 branched or linear alkyl esters of acrylic acid; methacrylic acid; Cι-C3o branched or linear alkyl esters of methacrylic acid; acrylamides or methacrylamides wherein the amide group may be substituted with one or two Cι-C30 branched or linear alkyl groups; vinyl esters, preferably vinyl acetates; other compounds having a vinyl group wherein said compounds are preferably selected from pyrrolidones, imidazoles, pyridines, caprolactams, piperidones, benzene and derivatives thereof; C4-C20 alkadienes; lactones; lactams; and saturated or unsaturated heterocyclic compounds containing one to five oxygen atoms. Examples of suitable comonomers are acrylic acid, methyl acrylate, butyl acrylate, 2-ethylhexyl acrylate, 2-hydroxyethyl acrylate, N,N- dimethylacrylamide, N-isopropylacrylamide, methacrylic acid, methyl methacrylate, ethyl methacrylate, butyl methacrylate, isobutyl methacrylate, 2-ethylhexyl methacrylate, lauryl methacrylate, 2-hydroxy-ethyl methacrylate,, vinylacetate, N- vinylpyrrolidinone, 2-vinylpyridine-l -oxide, N-vinyl imidazole, N- vinyl pyridine, N- vinylcaprolactam, N-vinyl-2-piperidone, acrylonitrile, styrene, butadiene, isoprene, caprolacton, butyrolacton, caprolactam, ethyleenoxide, propyleneoxide, tetrahydrofuran, 3,6-dimethyl-l,4-dioxane-2,5-dione, l,4-dioxane-2,5-dione. The copolymerizations may be of any type (for example, bulk, dispersion, solution, emulsion, suspension or inverse phase emulsion) and of any mechanism (for example, radical polymerization, condensation polymerization, transition metal catalyzed polymerization, enzymatic polymerization, or ring opening polymerization). The copolymer backbone acquired may be of any type (linear, branched, star, hyperbranched, dendritic, comb-like or the like).
The product copolymer may be of any structure. For example random, regular, tapered or block copolymer structures are allowed.
According to the invention, the molecular weights of the polymers are preferably not too high. A preferred number average molecular weight range is 500 - 20000.
The copolymers according to the invention are in particular suitable for applications related to personal care (hair preparations, skin cosmetics and laundry aids), surface coatings (leather, textile, optical fibers, paper and paint formulations), imaging technologies (printing, stereolithography, photography and lithography), biomedical applications (materials for controlled release of drugs and materials for tissue-engineering, tablet formulation), adhesive and sealing compositions, and thickening agent and binders.
EXAMPLES
The following non-limiting examples further illustrate the preferred embodiments of the invention. When not specifically mentioned, chemicals are obtained from Aldrich.
Synthesis of building blocks
Example 1: synthesis of isocyanate I
Figure imgf000012_0001
1,6-Hexyldiisocyanate (650 g) and methyl isocytosine (or 2-amino-4-hydroxy-6- methyl-pyrimidine, 65.1 g) were suspended in a 2-liter flask. The mixture was stirred overnight at 100 °C under an argon atmosphere. After cooling to room temperature, a liter of pentane was added to the suspension, while stirring was continued. The product was filtered, washed with pentane and dried in vacuum. A white powder was obtained. 1HNMR (400 MHz, CDC13): δ 13.1 (1H), 11.8 (1H), 10.1 (1H), 5.8 (1H), 3.3 (4H), 2.1 (3H), 1.6 (4H), 1.4 (4H). FT-IR (neat): v 2935, 2281, 1698, 1668, 1582, 1524, 1256.
Example 2: synthesis of isocyanate II
Figure imgf000013_0001
Methyl isocytosine (5.2 g) was added to isophoronediisocyanate (IPDI, 50 mL) and subsequently stirred at 90 °C under an argon atmosphere for 3 days. The resulting clear solution was precipitated in heptane. The white gom was collected, heated in 150 mL heptane, cooled on ice, and filtered. The same procedure was repeated once more with the white residue, resulting in a white powder. 1H N R (400 MHz, CDC13): δ 13.1 (1H), 12.0 (1H), 10.1 (1H), 5.9 (1H), 4.1-3.1 (3H), 2.1 (3H), 2.0-0.9 (15H). FT-IR (neat): v (cm"1) 2954, 2255, 1696, 1662, 1582, 1524, 1247.
The product exists in four different isomers: the two regio-isomers depicted above are both present in cis and trans configuration. For reasons of clarity, only one isomer is depicted in the following schemes, although all four isomers are present.
Example 3: synthesis of isocyanate III
Figure imgf000013_0002
Methyl isocytosine (2.0 g) was added to 4,4'-methylenebis(phenylisocyanate) (MDI, 8.1 g) dissolved in 35 mL THF and subsequently stirred at an oil bath temperature of 75 °C under an argon atmosphere. After 4 hours, 40 mL chloroform was added and the white precipitate was separated by filtration and washed with chloroform. 1H NMR (400 MHz, DMSO-d6): δ 10.0 (1H), 8.6 (1H), 7.4 (5H), 7.2 (4H), 5.8 (1H), 3.8 (2H), 2.1 (3H). FT-IR (neat): v (cm"1) 3329, 2954, 2257, 1699, 1658, 1578, 1508, 1244. Example 4: synthesis of isocyanate IV
Figure imgf000014_0001
A suspension of methyl isocytosine (2 g) and trimethyl-l,6-hexyldiisocyanate (a mixture of 2,2,4-trimethyl and 2,4,4-trimethyl isomers; 24 g) was stirred and heated for 21 hours at an oil bath temperature of 100 °C. The mixture was kept under an argon atmosphere. The reaction mixture was cooled down to room temperature and pentane was added to induce precipitation. The suspension was filtrated over a glass filter and the gummy residue was stirred and heated again in pentane. Cooling, filtration and drying gave a white powder. 1H NMR (300 MHz, CDC13): δ = 13.1 (1H), 11.7 (1H), 10.1 (1H), 5.8 (1H), 3.4-3.0 (4H), 2.2 (3H), 1.8 (1H), 1.6 (2H), 1.3 (1H), 1.1 (1H), 1.05-0.95 (9H). FT-IR (neat): υ (cm-1) 2933, 2260, 1693, 1647, 1580, 1518, 1248. The product exists in eight isomers, as both trimethyl hexyldiisocyanates are chiral and can react at both isocyanate positions. For reasons of clarity, only one isomer is depicted (without assignment of stereocenter), although all isomers are present.
Example 5: synthesis of ό-(l-ethylpentyl) -isocytosine
Figure imgf000014_0002
Potassium ethyl malonate (150 g) and acetonitrile (1.4 L) were stirred in a flask and brought to a temperature of 10-15 °C. Triethylamine (132 mL) was added drop wise, while keeping the mixture under an argon atmosphere. Dried MgCl2 (101.6 g) was added and the suspension was stirred for 2 hours at room temperature. Thereafter, the suspension was cooled to 0 °C and 2-ethylhexanoyl chloride (74 mL) was added drop wise, and the mixture was allowed to warm up to room temperature and was stirred overnight. The acetonitrile was removed by evaporation, 400 mL toluene was added and evaporated, 700 mL of toluene was added and the mixture was cooled to 10 °C. An aqueous HC1 solution was added slowly, and the organic layer was separated, washed with an HC1 solution and then with a bicarbonate solution. The organic layer was dried with Na2SO4 and concentrated to give the β-ketoester as a liquid. The β-ketoester (50 g) and guanidine carbonate (49.8 g) were boiled in ethanol (300 mL) for two days using a Soxhlett set-up with molsieves in the thimble. The suspension was filtered, ethanol was evaporated and the product was dissolved in chloroform. After washing with a bicarbonate solution, the organic layer was dried with MgSO4, concentrated and dropped into an excess of pentane to yield a white powder. 1H NMR (400 MHz, CDC13): δ 11.6-10.6 (1H), 7.6-6.6 (2H), 5.6 (1H), 2.2 (1H), 1.5 (4H), 1.2 (4H), 0.8 (6H). FT-IR (neat): v 3322, 3152, 2929, 2860, 1635, 1463, 1378, 1582, 1524.
Synthesis of 4H hydrogen bonding unit containing monomers
Example 6: monomer 1, a 4H hydrogen bonding unit containing methacrylate monomer
Figure imgf000015_0001
Isocyanate II (28 g) was dissolved in chloroform (0.5 L), and thereafter hydroxy ethyl methacrylate (HEMA, 9.6 mL) and 8 drops of dibutyl tin dilaurate (DBTDL) were added. The mixture was stirred at an oil bath temperature of 90 °C for 4 hours, and was then cooled and filtered. The filtrate was concentrated and dropped into an excess of diethylether. The precipitate was collected by filtration, and was washed with diethylether. Drying in vacuo gave a solid product. 1H NMR (400 MHz, CDC13): δ 13.1 (1H), 11.8 (1H), 10.1 (1H), 6.1 (1H), 5.8 (1H), 5.6 (1H), 5.0 (1H), 4.3 (4H), 4.1-3.6 (1H), 3.1-2.9 (2H), 2.1 (3H), 2.0 (3H), 1.8-1.5 (2H), 1.4-0.8 (13H). FT-IR (neat): v 3212, 2954, 1697, 1660, 1572, 1520, 1242, 1165.
Example 7: monomer 2, a 4H hydrogen bonding unit containing acrylate monomer
Figure imgf000015_0002
Isocyanate I (46 g) was suspended in chloroform (1 L), and thereafter hydroxy ethyl acrylate (HEA, 36 mL) and 10 drops of dibutyl tin dilaurate (DBTDL) were added. The mixture was stirred at an oil bath temperature of 90 °C for 4 hours, and was then cooled and filtered. The filtrate was concentrated and an excess of diethylether was added. The white precipitate was collected by filtration, and was washed with diethylether. Drying in vacuo gave a white solid product. 1H NMR (400 MHz, CDC13): δ 13.1 (IH), 11.8 (IH), 10.1 (IH), 6.5 (IH), 6.2 (IH), 5.9 (2H), 5.1 (IH), 4.4 (4H), 3.3 (2H), 3.2 (2K), 2.1 (3H), 1.7-1.3 (8H). FT-IR (neat): v 3307, 2928, 1725, 1702, 1682, 1664, 1584, 1548, 1258, 1192.
Example 8: monomer 3, a 4H hydrogen bonding unit containing methacrylate monomer
Figure imgf000016_0001
2-Isocyanatoethyl methacrylate (7.0 mL) was added to a solution of 6-(l-ethylpentyl)- isocytosine (13.4 g) in dry pyridine (150 mL). The reaction mixture was stirred under an argon atmosphere at 80 °C for 4 hrs. The product was worked-up by evaporation of the solvent, and subsequent filtration over silica using chloroform/methanol (4%).
Silica column chromatography using ethyl acetate/hexane yielded a light yellowish waxy solid. 1H NMR (400 MHz, CDC13): δ 13.1 (IH), 12.0 (IH), 10.5 (IH), 6.2 (IH), 5.8 (IH), 5.6 (IH), 4.3 (2H), 3.6 (2H), 2.3 (IH), 1.9 (3H), 1.8-1.5 (4H), 1.4-1.2 (4H),
0.9 (6H). FT-IR (neat): v 2959, 2930, 1720, 1697, 1645, 1582, 1555, 1525, 1462, 1254,
1160.
Example 9: monomer 4, a 4H hydrogen bonding unit containing methacrylate monomer
Figure imgf000016_0002
PEG-MA alcohol (with an average molecular weight Mn of 360; 2.2 g), isocyanate I (1.8 g) and a few drops of DBTDL were boiled overnight in chloroform. Hexane was added to cause precipitation. The product was isolated by filtration, washing with hexane and with diethyl ether. 1H NMR (400 MHz, DMSO-d6): δ 7.5 (IH), 7.2 (IH), ! 6.0 (IH), 5.7 (IH), 5.6 (IH), 4.2 (2H), 4.0 (2H), 3.7 (2H), 3.6-3.4 (15H-20H), 3.1 (2H), 2.9 (2H), 2.1 (3H), 1.9 (3H), 1.4 (4H), 1.2 (4H).
Example 10: monomer 5, a 4H hydrogen bonding unit containing acrylamide monomer
Figure imgf000017_0001
Isocyanate I (1 g) was dissolved in 5 mL of acrylic acid and heated to 60 °C. The mixture was stirred under an argon atmosphere. Copper(II)acetate (8 mg) was added and heating at 60 °C was maintained for 2 hours. The product was obtained by precipitation of the reaction mixture into diethylether. Then the solid was filtered, dissolved in chloroform and washed with a bicarbonate solution. Drying with Na SO4 and column chromatography using chloroform with 10% methanol gave a white powder. 1H NMR (400 MHz, CDCl3/CD3OD): δ 7.4 (IH), 6.3-6.1 (2H), 5.8 (IH), 5.6 (IH), 3.3-3.2 (4H), 2.1 (3H), 1.7-1.2 (8H). FT-TR (neat): v 3278, 2935, 1699, 1665, 1652, 1582, 1525.
Example 11: monomer 6, a 4H hydrogen bonding unit containing vinyl-ester monomer
Figure imgf000017_0002
6-(l-Ethylpentyl)-isocytosine (3.5 g) was dissolved in 50 mL THF followed by the addition of 2.5 mL ethyl 3-isocyanato ethylacetate. Stirring the reaction mixture under reflux for 16h resulted in the formation of a white powder that was filtered and washed 5 with chloroform (4.8 gram). This compound was subsequently dissolved in a mixture of ethanol (50 mL) and 1 N aqueous sodium hydroxide (40 mL) and stirred for 2 h at room temperature. Addition of a saturated solution of KHSO4 in water to the ice-cooled reaction mixture until the pH=3, resulted in the formation of a white precipitate that was subsequently filtrated and washed with water. After drying in vacuo 4.4 gram of the carboxylic acid functional ureidopyrimidone was isolated. A mixture of the carboxylic acid functional ureidopyrimidone (2.0 gram), mercuric acetate (30 mg), vinylacetate (4.0 gram), and concentrated sulfuric acid (15 uL) was stirred for 2 days at 60 °C. The reaction mixture was subsequently precipitated in diethylether. After filtration and drying in vacuo, 4H vinylacetate was obtained as a white powder (2.9 gram).
Example 12: monomer 7, a 4H hydrogen bonding unit containing styrene monomer
Figure imgf000018_0001
Isocyanate I (5.6 g) was added to 4-aminostyrene (obtained from Aldrich 1.9 g) dissolved in 50 mL of chloroform and subsequently heated to 70 °C. The mixture was stirred under an argon atmosphere for 12h. The product was obtained by separation of the yellowish precipitate from the reaction mixture by filtration, followed by washing with chloroform. 1H NMR (400 MHz, CDCl3/DMSO-d6): δ 7.8 (IH), 7.2 (4H), 6.6 (IH), 5.8 (IH), 5.5 (IH), 5.1 (IH), 3.4-3.2 (4H), 2.1 (3H), 1.7-1.2 (8H). FT-IR (neat): v 3278, 2935, 1699, 1665, 1652, 1582, 1525.
Example 13: monomer 8, a 4H hydrogen bonding unit containing ε-lacton monomer
Figure imgf000018_0002
A solution of 4-(4-hydroxyphenyl)-cyclohexanone (obtained from Fluka, 8.2 g) dissolved in 100 mL of 2-butanone was added drop wise to a stirred solution of 3- chloroperoxybenzoic acid (9.3 g) in 40 mL 2-butanone. After 5h the reaction mixture was concentrated in vacuo to 30% of its original volume followed by the addition of 50 mL diethylether. The resulting white precipitate was collected by filtration and dried in vacuo. The resulting white powder was redissolved in 150 mL chloroform to which isocyanate II was added (11.8 g) and 4 drops dibutyltinlaureate. The mixture was stirred at reflux under an argon atmosphere for 16h. The product was obtained by precipitation in diethylether. 1H NMR (400 MHz, CDC13): δ 13.1 (IH), 12.0 (IH), 10.1 (IH), 7.3-7.0 (4H), 5.9 (IH), 5.4-5.0 (IH), 4.4 (2H), 4.1-3.8 (2H), 3.2-2.6 (4H) 2.2-0.9 (22H). IR (neat): v 3211, 2955, 1724, 1699, 1660, 1575, 1505, 1247, 1211.
Example 14: monomer 9, a 4H hydrogen bonding unit containing acrylate monomer
Figure imgf000019_0001
Isocyanate IN (11 g) was dissolved in chloroform (150 mL), and thereafter hydroxy ethyl acrylate (HEA, 4.1 mL) and 4 drops of dibutyl tin dilaurate (DBTDL) were added. The mixture was stirred at an oil bath temperature of 60 °C for 9 hours, and was then cooled and precipitated in pentane, followed by a washing step with diethylether.
The white powder was collected by filtration, and was washed with diethylether.
Drying in vacuo gave a white solid product. 1H ΝMR (400 MHz, CDC13): δ 13.1 (IH), 11.8 (IH), 10.1 (IH), 6.5 (IH), 6.2 (IH), 5.9 (2H), 5.4 and 5.1 (IH), 4.4 (4H), 3.3-2.9
(4H), 2.1 (3H), 1.8-0.9 (14H).
Example 15: monomer 10, a 4H hydrogen bonding unit containing methacrylate monomer
Figure imgf000019_0002
The isocyanate (79 g) was suspended in chloroform (1.5 L), and thereafter hydroxy ethyl methacrylate (HEMA, 64 mL) and 15 drops of dibutyl tin dilaurate (DBTDL) were added. The mixture was stirred at an oil bath temperature of 90 °C for 4 hours, and was then cooled and filtered. The filtrate was concentrated and dropped into an excess of diethylether. The white precipitate was collected by filtration, and was washed with diethylether. Drying in vacuo gave a white solid product (90 g). !H NMR (400 MHz, CDC13): δ 13.1 (IH), 11.8 (IH), 10.1 (IH), 6.1 (IH), 5.8 (IH), 5.6 (IH), 5.0 (IH), 4.3 (4H), 3.3-3.2 (4H), 2.1 (3H), 1.9 (3H), 1.7-1.2 (8H). FT-TR (neat): v 3301, 2932, 1720, 1699, 1685, 1665, 1582, 1525, 1258.
Synthesis of co-polymers Examples of co-polymers containing 4H hydrogen bonding units were obtained via several different polymerization techniques that are known in the art. Results can be found in Table 1, general procedures are given below:
Atom transfer radical polymerization (ATRP) procedure Preparation ofpoly-HEMA polymers (polymers A-E).
A 25 mL round bottom flask containing CuBr (ca. 1 equiv. to initiator; typically 0.06 to 0.31 g), 2,2'-bipyridine (ca. 2 equiv. to initiator) and the appropriate amount of 4H hydrogen bonding unit containing monomer was degassed (de-oxygenated) by vacuum followed by argon backfill, and repeating this cycle twice. HEMA, DMSO (in equal volumes, typically both 2 to 5 mL) and optionally PEG-MA (average Mn = 360 Dalton; for polymers B and C) were degassed (de-oxygenated) by bubbling through argon for at least 45 minutes, and were then added to the 25 mL flask by use of a syringe. The reaction mixture was stirred until all components had dissolved (sometimes after short warming) to produce a homogeneous dark brown solution. The reaction flask was placed in a water bath that was maintained at room temperature, and finally, the ATRP- initiator (benzyl-2-bromo-2-methyl-propionate) was added using a syringe. The molar ratio of ATRP initiator to HEMA was about 1:40 (for polymers A, C, D and E) and about 1:20 for polymer B. Polymerization occurred immediately, leading to an increase in viscosity of the reaction mixture. After ca. half an hour, the polymer was isolated by precipitation into an EDTA (25 gL) solution in water (polymers B-E), or in chloroform (polymer A). The polymer was washed and dried.
Preparation ofPMMA polymers (polymers F-G).
A flask containing NiBr2(PPh3)2 (ca. 0.35 g) and, optionally, the 4H hydrogen bonding unit containing monomer 3 was degassed (de-oxygenated) by vacuum followed by argon backfill, and repeating this cycle twice. MMA and toluene (in equal volumes; both 5 mL) were degassed (de-oxygenated) by bubbling through argon for at least 45 minutes, and were then added to the flask by use of a syringe. Finally, the ATRP- initiator (benzyl-2-bromo-2-methyl-propionate, ca. 185 mg) was added using a syringe The flask was placed in an oil bath of 70 °C and the polymerization was allowed to run for about 20 hours. The solution was filtered over alranina and flushed with chloroform/methanol, the filtrate was concentrated and dropped into hexane. The precipitate was dried.
Free radical polymerization (FR) procedures (polymers H-L)
A solution containing HEMA (5 mL), the appropriate 4H hydrogen bonding unit containing monomer, ATBN (12 mg) and transfer agent mercapto ethanol (75 microliter; 60 microliter for polymer I) in DMF (15 mL), was degassed by purging with argon for 1 hr prior to polymerization. Polymerization was conducted at 80 °C for about 3 to 4 hours, after which the mixture was cooled down to room temperature and the polymer was recovered by precipitation into a non-solvent (THF/hexane 3/1 was used for polymers H and I; water was used for polymers J-L), filtration and drying. For polymer H, different conditions were used: 4.7 mL HEMA, 30 mL DMF, monomer 3, 20 microliter mercapto ethanol and 22 mg ATBN were stirred at 60 °C for two days; the ATBN was added in two equal portions at the beginning and after 1 day of polymerization.
Ring-opening polymerization (ROP) procedure (polymer M)
Freshly distilled and dried ε-caprolacton, benzylalcohol (initiator) and pyridine (2 equiv. to initiator) were added to a Schlenck bottle in a nitrogen atmosphere that contained tin(II)trifluoromethanesulfonate (catalyst 0.5 equiv. to initiator) and the desired amount of monomer 8. The Schlenck bottle was placed in an oil bath and heated to 65 °C for 16 hours. The viscous reaction mixture was diluted with an equal volume of THF and subsequently precipitated in methanol, filtered and dried in vacuo.
Emulsion polymerization (EP) procedure (polymers N and O)
Butyl acrylate (5 mL), water (11 mL), optionally monomer 9 (0.67 g), sodium dodecyl sulphate (0.1 g), charge transfer agent dodecyl mercaptane (0.3 mL), initiator sodium persulphate (25 mg for polymer N and 50 mg for polymer O) and sodium bicarbonate (30 mg for polymer N and 25 mg for polymer O) were mixed at 20 °C and purged with argon for 45 minutes. Subsequently, the reaction temperature was raised to 50 °C and the mixture was extensively stirred for 4 hours. The polymer product was isolated after coagulation of the emulsion by addition of methanol.
Table 1
Figure imgf000022_0001
- = not determined; * Mtop (kD)
Characterization
Molecular weights (Mn) of polymers A-E, and M were determined with 1H NMR by considering the integral of the benzylic end group versus the integral of the repeating unit. The molecular weights (Mn) and dispersities (D) of polymers B, C and I were determined with SEC (0.01 M LiBr in DMF) against polystyrene standards (a comparison with the NMR data for polymers B and C shows that the Mn and D values from the SEC-measurements are overrated). The molecular weights (Mn or Mtop) and dispersities (D) of polymers F, G, N and O were determined with SEC (THF) against polystyrene standards.
Additionally, 1H NMR in deuterated chloroform or DMSO-d6 has been used to calculate the average number of 4H hydrogen bonding units per polymer chain by considering the integral of the benzylic signals of the polymer end group and the integral of the alkylidene signal of the 4H hydrogen bonding unit in case of polymers A-G and M. Polymers H-L and N contain incorporated 4H hydrogen bonding units, as evidenced by 1H NMR data. Polymer properties
The effect of incorporation of 4H hydrogen bonding units in the polymer chain is clearly demonstrated in the solution (kinematic) viscosity of PMMA-sarnples at 20 °C, see Table 2. As can be seen, incorporation of 4H hydrogen bonding units according to this invention has a pronounced and unique thickening effect.
Table 2
Figure imgf000023_0001
polymer F and G have a comparable molecular weight, see table 1.
Incorporation of 4H hydrogen bonding units in polymers according to this invention also gives enhancement in material properties, as most clearly reflected in the difference in properties of polymers N and O. While poly(butylacrylate) O is a sticky viscous liquid, poly(butylacrylate) N with incorporated 4H hydrogen bonding units is an elastic material even despite the fact that polymer N has a lower molecular weight than polymer O.

Claims

1. A monomer comprising (a) a monomeric unit having a group that can be polymerized (i.e. a monomeric unit having a polymerizable group), a linking moiety (b) and a structural element (c) capable of forming at least four hydrogen bridges, wherein the monomer has the general structure (a) - (b) - (c).
2. The monomer according to claim 1, wherein the structural element (c) has the general form (1) or (2):
Figure imgf000024_0001
(l1) (2')
wherein the C-X, (i = 1 - 4) and the C-Y, (i = 1 - 4) linkages each represent a single or double bond and X,- represent donors or acceptors that form hydrogen bridges with the H-bridge forming monomeric unit containing a corresponding general form (2) linked to them with X,- representing a donor and Y,- an acceptor or vice versa.
3. The monomer according to claim 2, wherein
Figure imgf000024_0002
and X2 are donors and X3 and are acceptors.
4. The monomer according to claim 2, wherein the donors and acceptors are O, S, and N atoms.
5. The monomer according to claim 2, wherein the structural element (c) has the general formula (3) or (4), or tautomers thereof:
(3) (4)
wherein the structural element (c) is bonded to the linking moiety (b) at Ri, R2 or R3 (so that Rl5 R2 or R3 represent a direct bond) with the other R groups representing a random side chain or are hydrogen atoms.
6. A process for the preparation of a monomer as defined in claim 1, wherein a monomeric unit having a polymerizable group is reacted in a first step with a compound having at least two functional groups and wherein the product obtained in the first step is reacted with a nitrogen containing compound.
7. A process for the preparation of a monomer as defined in claim 1, wherein a nitrogen containing compound is reacted in a first step with a compound having at least two functional groups and wherein the product obtained in the first step is reacted with a monomeric unit having a polymerizable group.
8. A process for the preparation of a monomer as defined in claim 1, wherein the nitrogen containing compound is reacted directly with the monomeric unit having a polymerizable group wherein the monomeric unit is able to form a urea linkage between both reactants.
9. A copolymer comprising the monomer as defined in claim 1 and at least one comonomer.
10. The copolymer according to claim 9, wherein the comonomer is selected from the group of: acrylic acid; Cι-C30 branched or linear alkyl esters of acrylic acid; methacrylic acid; Cj.-C30 branched or linear alkyl esters of methacrylic acid; acrylamides or methacrylamides wherein the amide group may be substituted with one or two Cι-C3o branched or linear alkyl groups; vinyl esters, preferably vinyl acetates; other compounds having a vinyl group wherein said compounds are preferably selected from pyrrolidones, imidazoles, pyridines, caprolactams, piperidones, benzene and derivatives thereof; C4-C20 alkadienes; lactones; lactams; and saturated or unsaturated heterocyclic compounds containing one to five oxygen atoms.
11. The copolymer according to claim 9, wherein the copolymer is a linear, branched, star, hyperbranched, dendritic or comb-like copolymer
12. The copolymer according to claim 9, wherein the copolymer has a random, regular, tapered or block structure.
13. A process for the preparation of a copolymer, wherein a monomer as defined in claim 1 is polymerized with at least one comonomer.
14. The process according to claim 13, wherein the process is conducted in bulk, dispersion, solution, emulsion, suspension or inverse phase emulsion.
PCT/NL2003/000586 2002-08-16 2003-08-15 Monomers capable of forming four hydrogen bridges and supramolecular polymers formed by copolymerization of these monomers with regular monomers WO2004016598A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2003258887A AU2003258887A1 (en) 2002-08-16 2003-08-15 Monomers capable of forming four hydrogen bridges and supramolecular polymers formed by copolymerization of these monomers with regular monomers
JP2004528958A JP4912590B2 (en) 2002-08-16 2003-08-15 Monomers capable of forming four hydrogen bridges and supramolecular polymers formed by copolymerization of these monomers with conventional monomers
EP03788181.0A EP1534688B1 (en) 2002-08-16 2003-08-15 Monomers capable of forming four hydrogen bridges and supramolecular polymers formed by copolymerization of these monomers with regular monomers

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40363602P 2002-08-16 2002-08-16
US60/403,636 2002-08-16

Publications (2)

Publication Number Publication Date
WO2004016598A1 true WO2004016598A1 (en) 2004-02-26
WO2004016598A8 WO2004016598A8 (en) 2005-11-24

Family

ID=31888258

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL2003/000586 WO2004016598A1 (en) 2002-08-16 2003-08-15 Monomers capable of forming four hydrogen bridges and supramolecular polymers formed by copolymerization of these monomers with regular monomers

Country Status (5)

Country Link
US (1) US6803447B2 (en)
EP (1) EP1534688B1 (en)
JP (1) JP4912590B2 (en)
AU (1) AU2003258887A1 (en)
WO (1) WO2004016598A1 (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006087475A1 (en) * 2005-02-15 2006-08-24 Arkema France Elastic materials
WO2006118461A2 (en) * 2005-05-04 2006-11-09 Suprapolix B. V. Modular bioresorbable or biomedical, biologically active supramolecular materials
WO2007058539A2 (en) * 2005-11-21 2007-05-24 Suprapolix B.V. Modular supramolecular materials for biomedical uses
EP1797867A1 (en) * 2005-12-16 2007-06-20 L'Oréal Cosmetic or pharmaceutical composition comprising a copolymer containing at least one ionisable group, and cosmetic treatment
WO2008051318A2 (en) 2006-10-25 2008-05-02 University Of Rochester Shape memory polymers
WO2008063057A3 (en) * 2006-11-20 2009-01-15 Suprapolix Bv Supramolecular polymers from low-melting, easily processable building blocks
WO2010001041A2 (en) * 2008-07-04 2010-01-07 L'oreal Cosmetic composition, cosmetic treatment method, and compound
WO2010002262A1 (en) * 2008-07-04 2010-01-07 Suprapolix B.V. High flow supramolecular compounds
US7862805B2 (en) 2001-06-07 2011-01-04 L'oreal Cosmetic composition forming after application a supramolecular polymer
WO2011080494A2 (en) 2010-01-04 2011-07-07 L'oreal Cosmetic composition, cosmetic treatment method, kit, and compound
WO2011080043A1 (en) * 2010-01-04 2011-07-07 L'oreal Ureidopyrimidones; cosmetic use as uv-screening agents; antisun compositions containing them
WO2011083243A1 (en) 2010-01-05 2011-07-14 L'oreal Cosmetic treatment methods and kit
US8172873B2 (en) 2006-10-25 2012-05-08 University Of Rochester Shape memory polymers
EP2457940A1 (en) 2010-11-24 2012-05-30 SupraPolix B.V. Fluorinated supramolecular polymers
US8268952B2 (en) 2004-07-12 2012-09-18 Suprapolix B.V. Supramolecular ionomers
WO2013004982A2 (en) 2011-07-07 2013-01-10 L'oreal Cosmetic treatment processes and kit
US8628789B2 (en) 2007-03-23 2014-01-14 Suprapolix, B.V. Strong reversible hydrogels
US9006386B2 (en) 2010-11-05 2015-04-14 Suprapolix B.V. Process for the preparation of a supramolecular polymer

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7025813B2 (en) * 2001-10-25 2006-04-11 Agfa-Gevaert Ink composition containing a particular type of dye, and corresponding ink-jet printing process
AU2003236849A1 (en) * 2002-05-27 2003-12-12 Huntsman International Llc Foamed supramolecular polymers
US20060160974A1 (en) * 2002-08-23 2006-07-20 Schulte Jorg L Novel polyvinyl esters
US6899992B2 (en) * 2002-11-08 2005-05-31 Kodak Polychrome Graphics Llc Polymerizable compounds with quadruple hydrogen bond forming groups
US7471614B2 (en) 2003-08-29 2008-12-30 International Business Machines Corporation High density data storage medium
US7463572B2 (en) 2003-08-29 2008-12-09 International Business Machines Corporation High density data storage medium
DK1687378T3 (en) * 2003-11-04 2014-03-03 Suprapolix Bv Preparation of supramolecular polymers containing four hydrogen bonding units in the polymer backbone
ATE512200T1 (en) * 2005-05-04 2011-06-15 Suprapolix Bv HYDROGELES WITH HYDROGEN BONDS
JP4756501B2 (en) * 2005-11-09 2011-08-24 リンテック株式会社 Method for producing photodegradable polymer compound
EP1792925B1 (en) 2005-12-01 2015-10-07 Henkel AG & Co. KGaA Novel material forming supramolecular structures, process and uses
US8102753B2 (en) 2006-02-21 2012-01-24 International Business Machines Corporation Method for forming deformed regions in a resin layer
US20070195682A1 (en) 2006-02-21 2007-08-23 Duerig Urs T Method for high density data storage and imaging
US7919562B2 (en) 2006-05-31 2011-04-05 The University Of Western Ontario Preparation of supramolecular polymers containing sequence-selective hydrogen bonding subunits in their backbone which form double helices
US20080076903A1 (en) * 2006-08-31 2008-03-27 Duerig Urs T Data storage medium and method for high density data storage
KR100730237B1 (en) 2006-09-18 2007-06-19 연세대학교 산학협력단 Preparation method of polymers containing quadruple hydrogen bonding
US7811370B2 (en) * 2007-04-24 2010-10-12 Xerox Corporation Phase change ink compositions
CN102040734B (en) * 2010-10-15 2012-12-12 华东理工大学 Thermal restoring net-structured hydrogen bond supermolecule elastomeric polymer and preparation method thereof
EP3016996B1 (en) * 2013-09-27 2017-06-14 Rohm and Haas Company Floor coating compositions containing supramolecular polymers
WO2016018145A1 (en) 2014-07-28 2016-02-04 Suprapolix B.V. Durable hydrogen bonded hydrogels
JP6496967B2 (en) * 2014-11-25 2019-04-10 花王株式会社 Polymer for cosmetics
KR101812238B1 (en) * 2015-02-03 2017-12-26 주식회사 엘지화학 Coating composition and coating film prepared therefrom
WO2016126102A1 (en) * 2015-02-03 2016-08-11 주식회사 엘지화학 Coating composition and coating film prepared therefrom
JP6825239B2 (en) * 2016-06-15 2021-02-03 三菱ケミカル株式会社 Acrylic resin and molded products of acrylic resin
EP3473672A4 (en) * 2016-06-16 2019-08-14 Bridgestone Corporation Additive for rubber
US11174413B2 (en) * 2018-07-13 2021-11-16 Corning Incorporated Optical fiber coating compositions with hydrogen bonding, non-covalent bonding, cross-linkers
CN109485609A (en) * 2018-12-10 2019-03-19 常州大学 A kind of preparation method of urea groups pyrimidone precursor
JP2023520783A (en) * 2020-04-03 2023-05-19 コベストロ (ネザーランズ) ビー.ヴィー. Self-healing oligomers and their uses
US11358899B2 (en) 2020-04-03 2022-06-14 Covestro (Netherlands) B.V. Self-healing optical fibers and the compositions used to create the same
CN111484597B (en) * 2020-04-16 2021-06-11 广州市白云化工实业有限公司 Modified polyurethane prepolymer, bi-component polyurethane adhesive and preparation method thereof
KR102262932B1 (en) * 2020-05-07 2021-06-08 인천대학교 산학협력단 A graft copolymer, a method for producing the same, a polymer binder for a silicon anode including the same, a silicon anode including the polymer binder for the silicon anode, and a lithium ion battery including the silicon anode
EP4098456A1 (en) 2021-05-31 2022-12-07 Société BIC Self-healing seal assembly for a writing instrument
ES2970697T3 (en) * 2021-09-10 2024-05-30 Evonik Operations Gmbh spaced urea (meth)acrylates
EP4148040B1 (en) * 2021-09-10 2023-11-01 Evonik Operations GmbH One pot synthesis of urea (meth)acrylates

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2461943A (en) 1949-02-15 Alpba
US2694687A (en) 1953-04-10 1954-11-16 Rohm & Haas Vinyloxyalkylmelamines
US2744943A (en) 1954-08-18 1956-05-08 Rohm & Haas Methacrylamidoacylguanamines
FR1350973A (en) 1962-02-06 1964-01-31 Geigy Ag J R New polymerizable acylmelamines and their preparation
US3290350A (en) 1960-05-16 1966-12-06 Du Pont Alpha, alpha, alpha', alpha'-tetramethyl-xylylene diisocyanates and alpha, alpha-dimethylisopropenylbenzyl isocyanates and the preparation thereof from isocyanic acid and olefins
JPS51125092A (en) * 1974-08-26 1976-11-01 Toyama Chem Co Ltd A process for preparing novel substituted s-triazines
JPS51125032A (en) 1974-07-19 1976-11-01 Chinoin Gyogyszer Es Vegyeszet Preparation of novel basic ether
EP0624605A2 (en) 1993-05-10 1994-11-17 Cytec Technology Corp. Copolymeric aminoplasts, method of producing and use of same
US6320018B1 (en) 1996-10-04 2001-11-20 Dsm N.V. Supramolecular polymer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4216318A (en) * 1975-12-29 1980-08-05 Smith Kline & French Laboratories Limited Heterocyclic alkyl 4-pyrimidones
AR244756A1 (en) * 1988-05-13 1993-11-30 Vilmax S A New coloured monomers and polymers, the procedure for preparing these polymers and the procedure for separating biologically active substances through the use of these polymers.
US5610268A (en) * 1992-01-13 1997-03-11 Dsm N.V. Dendritic macromolecule and the preparation thereof
ATE158588T1 (en) * 1992-04-16 1997-10-15 Zeneca Ltd PEPTIDES WITH AN ALPHAAMINOBORONAIRE GROUP AND THEIR USE AS ELASTIC INHIBITORS
US5451638A (en) * 1993-05-10 1995-09-19 Cytec Technology Corp. Copolymeric aminoplast crosslinking agents

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2461943A (en) 1949-02-15 Alpba
US2694687A (en) 1953-04-10 1954-11-16 Rohm & Haas Vinyloxyalkylmelamines
US2744943A (en) 1954-08-18 1956-05-08 Rohm & Haas Methacrylamidoacylguanamines
US3290350A (en) 1960-05-16 1966-12-06 Du Pont Alpha, alpha, alpha', alpha'-tetramethyl-xylylene diisocyanates and alpha, alpha-dimethylisopropenylbenzyl isocyanates and the preparation thereof from isocyanic acid and olefins
FR1350973A (en) 1962-02-06 1964-01-31 Geigy Ag J R New polymerizable acylmelamines and their preparation
JPS51125032A (en) 1974-07-19 1976-11-01 Chinoin Gyogyszer Es Vegyeszet Preparation of novel basic ether
JPS51125092A (en) * 1974-08-26 1976-11-01 Toyama Chem Co Ltd A process for preparing novel substituted s-triazines
EP0624605A2 (en) 1993-05-10 1994-11-17 Cytec Technology Corp. Copolymeric aminoplasts, method of producing and use of same
US6320018B1 (en) 1996-10-04 2001-11-20 Dsm N.V. Supramolecular polymer

Non-Patent Citations (14)

* Cited by examiner, † Cited by third party
Title
EL-GHAYOURY, A. ET AL., ANGEW. CHEM. INT. ED., vol. 40, 2001, pages 3660
EL-GHAYOURY, A. ET AL., CHEM. COMMUN., 2000, pages 1969
EL-GHAYOURY, A. ET AL.: "Quadruple hydrogen bonded oligo(p-phenylene vinylene) dimers", CHEM. COMMUN., 2000, pages 1969 - 1970, XP002260391 *
EL-GHAYOURY, A. ET AL.: "Supramolecular hydrogen-bonded oligo(p-phenylene vinylene) polymers", ANGEW. CHEM. INT. ED., vol. 40, no. 19, 2001, pages 3660-3663, XP002260390 *
FOLMER, B.J.B. ET AL., ADV. MATER., vol. 12, 2000, pages 874
HERWEH, J.E. & WHITMORE, W.Y.: "Synthesis and Characterization of 2-Ureylene-4,6-diamino-s-triazines", J. CHEM. ENG. DATA, vol. 15, no. 4, 1970, pages 593 - 595, XP002260389 *
HERWEH, J.E.; WHITMORE, W.Y, J CHEM. ENG. DATA, vol. 15, 1970, pages 193
HIRSCHBERG ET AL., MACROMOLECULES, vol. 32, 1999, pages 2696
LANGE F.M. ET AL., MACROMOLECULES, vol. 28, 1995, pages 782
PATENT ABSTRACTS OF JAPAN vol. 001, no. 012 (C - 004) 22 March 1977 (1977-03-22) *
RIETH, L.R. ET AL., ANGEW. CHEM. INT. ED., vol. 40, 2001, pages 2153
RIETH, L.R., EATON, R.F., COATES, G.W.: "Polymerization of ureidopyrimidinone-functionalized olefines by using late-transition metal Ziegler-Natta catalysts: synthesis of thermoplastic elastomeric polyolefins", ANGEW. CHEM. INT. ED., vol. 40, no. 11, 2001, Weinheim, pages 2153 - 2156, XP002260388 *
SCIENCE, vol. 278, pages 1601
YAMAUCHI, K; LIZOTTE, J.R., LONG, T.E.: "Thermoreversible poly(alkyl acrylates) consisting of self-complementary multiple hydrogen bonding", MACROMOLECULES, vol. 36, no. 4, 2003, pages 1083 - 1088, XP002260387 *

Cited By (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7862805B2 (en) 2001-06-07 2011-01-04 L'oreal Cosmetic composition forming after application a supramolecular polymer
US8354097B2 (en) 2001-06-07 2013-01-15 L'oreal Cosmetic composition forming after application a supramolecular polymer
US8268952B2 (en) 2004-07-12 2012-09-18 Suprapolix B.V. Supramolecular ionomers
WO2006087475A1 (en) * 2005-02-15 2006-08-24 Arkema France Elastic materials
US9339586B2 (en) 2005-05-04 2016-05-17 Suprapolix B.V. Modular bioresorbable or biomedical, biologically active supramolecular materials
US9907637B2 (en) 2005-05-04 2018-03-06 Suprapolix B.V. Modular bioresorbable or biomedical, biologically active supramolecular materials
WO2006118461A2 (en) * 2005-05-04 2006-11-09 Suprapolix B. V. Modular bioresorbable or biomedical, biologically active supramolecular materials
US8883188B2 (en) 2005-05-04 2014-11-11 Suprapolix B.V. Modular bioresorbable or biomedical, biologically active supramolecular materials
JP2008539859A (en) * 2005-05-04 2008-11-20 スープラポリックス ビー.ブイ. Modular bioabsorbable or biomedical bioactive supramolecular materials
WO2006118461A3 (en) * 2005-05-04 2007-10-04 Suprapolix Bv Modular bioresorbable or biomedical, biologically active supramolecular materials
WO2007058539A2 (en) * 2005-11-21 2007-05-24 Suprapolix B.V. Modular supramolecular materials for biomedical uses
WO2007058539A3 (en) * 2005-11-21 2008-04-17 Suprapolix Bv Modular supramolecular materials for biomedical uses
FR2894816A1 (en) * 2005-12-16 2007-06-22 Oreal COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A COPOLYMER HAVING AT LEAST ONE IONIZABLE GROUP AND COSMETIC TREATMENT METHOD
EP1797867A1 (en) * 2005-12-16 2007-06-20 L'Oréal Cosmetic or pharmaceutical composition comprising a copolymer containing at least one ionisable group, and cosmetic treatment
EP2084196A2 (en) * 2006-10-25 2009-08-05 University of Rochester Shape memory polymers
US8172873B2 (en) 2006-10-25 2012-05-08 University Of Rochester Shape memory polymers
WO2008051318A2 (en) 2006-10-25 2008-05-02 University Of Rochester Shape memory polymers
EP2084196A4 (en) * 2006-10-25 2011-06-22 Univ Rochester Shape memory polymers
WO2008063057A3 (en) * 2006-11-20 2009-01-15 Suprapolix Bv Supramolecular polymers from low-melting, easily processable building blocks
US9006364B2 (en) 2006-11-20 2015-04-14 Suprapolix B.V. Supramolecular polymers from low-melting, easily processable building blocks
US8628789B2 (en) 2007-03-23 2014-01-14 Suprapolix, B.V. Strong reversible hydrogels
US10377847B2 (en) 2007-03-23 2019-08-13 Suprapolix B.V. Strong reversible hydrogels
WO2010002262A1 (en) * 2008-07-04 2010-01-07 Suprapolix B.V. High flow supramolecular compounds
FR2933407A1 (en) * 2008-07-04 2010-01-08 Oreal COSMETIC COMPOSITION, COSMETIC PROCESSING METHOD AND COMPOUND
WO2010001041A2 (en) * 2008-07-04 2010-01-07 L'oreal Cosmetic composition, cosmetic treatment method, and compound
US8754213B2 (en) 2008-07-04 2014-06-17 Suprapolix B.V. High flow supramolecular compounds
US20110229724A1 (en) * 2008-07-04 2011-09-22 Suprapolix B.V. High flow supramolecular compounds
WO2010001041A3 (en) * 2008-07-04 2010-05-27 L'oreal Cosmetic composition method for cosmetic treatment and 4-oxo-1, 4-dihydr0pyrimidin-2-yl compounds
US8575341B2 (en) 2008-07-04 2013-11-05 L'oreal Cosmetic composition, cosmetic treatment method, and compound
WO2011080494A2 (en) 2010-01-04 2011-07-07 L'oreal Cosmetic composition, cosmetic treatment method, kit, and compound
WO2011080043A1 (en) * 2010-01-04 2011-07-07 L'oreal Ureidopyrimidones; cosmetic use as uv-screening agents; antisun compositions containing them
FR2954907A1 (en) * 2010-01-04 2011-07-08 Oreal COSMETIC COMPOSITION, COSMETIC PROCESSING METHOD, AND KIT
FR2954940A1 (en) * 2010-01-04 2011-07-08 Oreal UREIDOPYRIMIDONE COMPOUNDS; COSMETIC USE AS UV FILTER; SOLAR COMPOSITIONS CONTAINING SAME
US10813866B2 (en) 2010-01-04 2020-10-27 L'oreal Cosmetic composition, cosmetic treatment method, kit, and compound
US11141368B2 (en) 2010-01-04 2021-10-12 L'oreal Cosmetic composition, cosmetic treatment method, kit, and compound
WO2011083243A1 (en) 2010-01-05 2011-07-14 L'oreal Cosmetic treatment methods and kit
US9006386B2 (en) 2010-11-05 2015-04-14 Suprapolix B.V. Process for the preparation of a supramolecular polymer
EP2457940A1 (en) 2010-11-24 2012-05-30 SupraPolix B.V. Fluorinated supramolecular polymers
WO2013004982A2 (en) 2011-07-07 2013-01-10 L'oreal Cosmetic treatment processes and kit

Also Published As

Publication number Publication date
EP1534688A1 (en) 2005-06-01
JP2006508201A (en) 2006-03-09
JP4912590B2 (en) 2012-04-11
US20040034190A1 (en) 2004-02-19
AU2003258887A1 (en) 2004-03-03
EP1534688B1 (en) 2014-10-29
WO2004016598A8 (en) 2005-11-24
US6803447B2 (en) 2004-10-12

Similar Documents

Publication Publication Date Title
EP1534688B1 (en) Monomers capable of forming four hydrogen bridges and supramolecular polymers formed by copolymerization of these monomers with regular monomers
EP1687378B1 (en) Preparation of supramolecular polymers containing quadruple hydrogen bonding units in the polymer backbone
EP2087027B1 (en) Supramolecular polymers from low-melting, easily processable building blocks
DE60303324T2 (en) Dual-stimuli-responsible hydrogels and their synthesis methods
US8268952B2 (en) Supramolecular ionomers
CS223409B1 (en) Grafted copolymeres and method of preparation of the same
JP3253679B2 (en) Preparation of macromonomer and comb polymer
US5210274A (en) Ethylenically unsaturated, florine-containing urethane derivatives and process for their preparation
CN108250383B (en) Polyurethane elastomer with multiple crosslinking degrees and preparation method thereof
Green et al. Donor-acceptor-containing quinodimethanes. Synthesis and copolyesterification of highly dipolar quinodimethanes
Janssen et al. Preparation of supramolecular polymers by copolymerization of monomers containing quadruple hydrogen bonding units with regular monomers
Janssen et al. Monomers capable of forming four hydrogen bridges and supramolecular polymers formed by copolymerization of these monomers with regular monomers
EP3275909A1 (en) Novel polyacrylate-polysilane block copolymers
JP2658152B2 (en) Polysiloxane group-containing polymer
US20020165333A1 (en) Polyisocyanates having alkyl, silyl, siloxane, and carbamate groups and preparing method thereof
Miyamoto et al. Reactivity of Cyclic Imino Ether Salts Having Vinyl Group V. Spontaneous and Base-Catalyzed Polymerization of N-Protio Salts of 2-Alkenyl-2-oxazolines and 2-Alkenyl-5, 6-dihydro-4H-1, 3-oxazines
Janssen et al. Preparation of supramolecular polymers containing quadruple hydrogen bonding units in the polymer backbone and their application
Mulder Synthesis and Characterization of Novel Supramolecular Polymers
Cvetkovska et al. Macro‐azo‐initiators having poly (ethylene glycol) units: Synthesis, characterization, and application to AB block copolymerization
CN108017775B (en) Preparation method of polyurethane RAFT reagent
WO2007113082A1 (en) Process for preparing polyamide-polysiloxane block copolymers
Ling et al. Synthesis and polymerization of new (meth) acrylamides bearing a hindered piperidine and a hydroxyl group

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003788181

Country of ref document: EP

Ref document number: 2004528958

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2003788181

Country of ref document: EP

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 09/2004 UNDER (30) REPLACE "NL" BY "US"